Selected Start-Ups (10/03)
In Vivo briefly summarizes the technologies of these recently founded companies: Arbor Surgical Technologies Inc., BiPar Sciences Inc., Foamix Ltd., Receptor BioLogix Inc., Solidus Biosciences Inc and Teranode Corp.
You may also be interested in...
Drawing on 24 years as a legislator and another 16 years as a leading lobbyist for biopharma, Jim Greenwood sees an opportunity for industry to put drug pricing ‘behind us’ with a legislative compromise.
SENZA PDN showed Nevro's HF10 spinal cord stimulation therapy provided sustained relief to patients with painful diabetic neuropathy. Results of a separate trial showed HF10 improved outcomes in patients with non-surgical refractory back pain.
No device-related warning letters were released by the US FDA the week of 19 January.